{
  "catalogId": "fb713a3f-f53d-4e1f-be34-9e7124ee65f1",
  "name": "VOXZOGO 1.2 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "175 74 37700 00",
  "treatmentDescriptions": "Voxzogo is indicated for the treatment of achondroplasia in paediatric patients whose epiphyses are not closed. The diagnosis of achondroplasia should be confirmed by appropriate genetic testing.",
  "termsOfIssue": "Prescription required",
  "form": "powder and solvent for solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "VOSORITIDE 1.2 MG/VIAL",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "M05BX07",
      "name": "VOSORITIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VOXZOGO 1.2 MG 10 VIAL",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 10.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9492",
        "yarpa": "26103"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 26821.19739,
        "retailMargin": 10.0,
        "maxRetailPrice": 29503.31713,
        "maxPriceWithVAT": 34813.91266
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.882907"
  }
}